2022 - Research.com Rising Star of Science Award
His scientific interests lie mostly in Atrophy, Alzheimer's disease, Neuroscience, Positron emission tomography and Hippocampal formation. Renaud La Joie combines subjects such as Cognition, Neuropsychological test, Disease, Biomarker and Pediatrics with his study of Atrophy. His research integrates issues of Psychiatry, Dementia, Posterior cortical atrophy, Dysexecutive syndrome and Primary progressive aphasia in his study of Alzheimer's disease.
As part of one scientific family, he deals mainly with the area of Dementia, narrowing it down to issues related to the Hippocampus, and often Neuroimaging, Pathological, β amyloid and Cortex. His work deals with themes such as Youden's J statistic and Pathology, which intersect with Positron emission tomography. His work on Subiculum as part of general Hippocampal formation study is frequently linked to Anatomical space, therefore connecting diverse disciplines of science.
His primary scientific interests are in Disease, Neuroscience, Pathology, Atrophy and Neuroimaging. His Cognition research extends to the thematically linked field of Disease. His work carried out in the field of Neuroscience brings together such families of science as Alzheimer's disease and Semantic dementia.
His Alzheimer's disease research is multidisciplinary, incorporating elements of Standardized uptake value, Posterior cingulate and Frontotemporal dementia. The study incorporates disciplines such as Default mode network and Grey matter in addition to Atrophy. The various areas that Renaud La Joie examines in his Neuroimaging study include Biomarker and Pathological.
Renaud La Joie spends much of his time researching Disease, Neuroimaging, Pathology, Internal medicine and Dementia. His Disease study combines topics in areas such as Distribution and Atrophy. His Neuroimaging research is within the category of Neuroscience.
As part of the same scientific family, Renaud La Joie usually focuses on Pathology, concentrating on Standardized uptake value and intersecting with Neurofibrillary tangle. His Internal medicine research includes elements of Neurology and Oncology. His biological study spans a wide range of topics, including Positron emission tomography, Hyperintensity and Cognition, Cognitive impairment.
Renaud La Joie mostly deals with Dementia, Pathology, Disease, Positron emission tomography and Alzheimer's disease. Dementia is the subject of his research, which falls under Internal medicine. His study looks at the intersection of Internal medicine and topics like Oncology with Precision medicine.
His biological study deals with issues like Standardized uptake value, which deal with fields such as Neurofibrillary tangle, Pittsburgh compound B and Medical diagnosis. His study in Disease is interdisciplinary in nature, drawing from both Inflammation, Cognition and Atrophy. His studies in Amyloid integrate themes in fields like Apolipoprotein E and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.
Alexandre Bejanin;Daniel R Schonhaut;Renaud La Joie;Joel H Kramer.
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
Rik Ossenkoppele;Yolande A. L. Pijnenburg;David C. Perry;Brendan I. Cohn-Sheehy.
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.
Renaud La Joie;Audrey Perrotin;Louisa Barré;Caroline Hommet;Caroline Hommet.
The Journal of Neuroscience (2012)
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease.
Gaël Chételat;Renaud La Joie;Nicolas Villain;Audrey Perrotin.
NeuroImage: Clinical (2013)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Elisabeth H. Thijssen;Elisabeth H. Thijssen;Renaud La Joie;Amy Wolf;Amelia Strom.
Nature Medicine (2020)
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Anne Maass;Susan Landau;Suzanne L Baker;Andy Horng.
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
Sylvia Villeneuve;Gil D. Rabinovici;Gil D. Rabinovici;Gil D. Rabinovici;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Brendan I. Cohn-Sheehy;Cindee Madison.
Why musical memory can be preserved in advanced Alzheimer’s disease
Jörn Henrik Jacobsen;Jörn Henrik Jacobsen;Johannes Stelzer;Johannes Stelzer;Thomas Hans Fritz;Thomas Hans Fritz;Gael Chételat.
Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders
Eider M. Arenaza-Urquijo;Brigitte Landeau;Renaud La Joie;Katell Mevel.
Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease
Robin de Flores;Renaud La Joie;Gaël Chételat.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: